- Current and emerging myeloma treatment options
- Updates on myeloma maintenance therapy
- The role of clinical trials in the advancement of treatment
- Advances in treatment side effects management
- Communicating with your healthcare team
Robert Z. Orlowski, MD, PhD
Florence Maude Thomas Cancer Research Professor, Director, Myeloma Section
Departments of Lymphoma/Myeloma and Experimental Therapeutics
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Click here for synchronized audio and slides.
Sponsors and Supporters
This program is sponsored by The Leukemia & Lymphoma Society and supported by grants from Celgene Corporation, Millennium: The Takeda Oncology Company, Onyx Pharmaceuticals and Bristol-Myers Squibb.